The present invention provides isolated peptides or the fragments derived from SEQ ID NO: 42, which bind to an HLA antigen and induce cytotoxic T lymphocytes (CTL). The peptides may include one of the above mentioned amino acid sequences with substitution, deletion, or addition of one, two, or several amino acids sequences. The present invention also provides pharmaceutical compositions including these peptides. The peptides of this invention can be used for treating cancer.本發明揭示一種衍生自序列識別號：42或其片段之單離胜肽，其結合於HLA抗原並誘導細胞毒性T淋巴球(CTL)。本發明的胜肽可包括上述胺基酸序列有1、2或數個胺基酸序列經取代、刪除或加成的胺基酸序列的其中之一。本發明更提供包括這些胜肽的醫藥組合物。本發明之胜肽可用於治療癌症。
